Categories: News

ENDRA Life Sciences to Participate in Two Upcoming Investment Conferences

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

ANN ARBOR, MI / ACCESSWIRE / March 2, 2021 / ENDRA Life Sciences Inc. (ENDRA) (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that management will participate in two upcoming virtual investment conferences.

  • H.C. Wainwright Global Life Sciences Virtual Conference, March 9-10, 2021. Management will deliver a company presentation and will be available for one-on-one meetings. A webcast of the recorded presentation will be accessible on demand beginning Tuesday, March 9, 2021 for registered participants of the conference.
  • 33rd Annual ROTH Conference, March 15-19, 2021. Management will deliver a company presentation and will be available for one-on-one meetings. A webcast of the recorded presentation will be available on demand in the Investors section of ENDRA Life Sciences’ website starting March 8, 2021.

About ENDRA Life Sciences Inc.
ENDRA Life Sciences is the pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), a ground-breaking technology being developed to visualize tissue like MRI, but at 1/50th the cost and at the point of patient care. TAEUS® is designed to work in concert with the over 1 million ultrasound systems in use globally today. TAEUS® is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and inflammation (NASH), chronic liver conditions that affect over 1 billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, ENDRA is exploring several other clinical applications of TAEUS®, including visualization of tissue temperature during energy-based surgical procedures. For more information, please visit www.endrainc.com.

Company Contact:
David Wells
Chief Financial Officer
(734) 997-0464
investors@endrainc.com

Investor Relations Contact:
Kim Sutton Golodetz
LHA Investor Relations
(212) 838-3777
kgolodetz@lhai.com

SOURCE: ENDRA Life Sciences Inc.

View source version on accesswire.com:
https://www.accesswire.com/632459/ENDRA-Life-Sciences-to-Participate-in-Two-Upcoming-Investment-Conferences

Staff

Recent Posts

New Jersey Innovation Institute and Cognome Announce Strategic Partnership to Advance AI-Powered Healthcare Solutions

NEWARK, N.J., March 26, 2025 /PRNewswire/ -- The New Jersey Innovation Institute (NJII), and Cognome are…

5 hours ago

Buds Technology Unveils BudLogic V2: BudLogic V2 Empowers Hospice Providers with Data-Driven Productivity & Performance Insights

ROSWELL, Ga., March 26, 2025 /PRNewswire/ -- Buds Technology, a leader in innovative care management…

5 hours ago

DATAVANTAGE & ADVIZEX PARTNER TO ADVANCE AI-DRIVEN DATA PREP AND XaaS DATA SECURITY, GOVERNANCE

The relationship sets a new standard for AI-driven data preparation: Deliver seamless, end-to-end secure data…

5 hours ago

HOTELTONIGHT LAUNCHES EXCLUSIVE PERK: EARN AIRBNB CREDIT WITH EVERY HOTEL STAY

Bridging the gap between hotel and homestays, HotelTonight and Airbnb provide a flexible solution for…

5 hours ago

Comcast Business Expands Connectivity Solutions to Central Florida and Tampa Bay

Florida's Technology Leader Launches New Client Services Teams in Orlando and Tampa ORLANDO, Fla., March…

5 hours ago

Uncompromised Excellence: City of Peachtree City, GA Modernizes Emergency Response with Avive’s Connected AEDs–Life Already Saved

SAN FRANCISCO  , March 26, 2025 /PRNewswire/ -- In a bold move to strengthen emergency…

5 hours ago